KemPharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (NCEs) to treat serious medical conditions through its proprietary and broadly applicable Ligand Activated Therapy (LAT) approach. The company utilizes its LAT technology to generate improved prodrug versions of FDA approved drugs in the high needs areas of pain, ADHD and other CNS diseases.
|
|
|
11-50 employees
View all KemPharm, Inc. employees
|
|
Pharmaceuticals
|
|
1180 Celebration Boulevard, Celebration, FL 34747, US
|
|
2006
|
The decision makers in KemPharm, Inc. are Christopher Lauderback, Douglas Commerce, Rene Braeckman, etc. Click to Find KemPharm, Inc. decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.